A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia

Journal of Human Genetics

Volumn 48, Issue 9, 2003, Pages 447-450

  Ono, Shuji ^a   Ezura, Yoichi ^a   Emi, Mitsuru ^a   Fujita, Yuko ^a   Takada, Daisuke ^a   Sato, Keiko ^b   Ishigami, Tomoaki ^b   Umemura, Satoshi ^b   Takahashi, Kaneo ^c   Kamimura, Kouhei ^c   Bujo, Hideaki ^d   Saito, Yasushi ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Awa Medical Association Hospital   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

G substrate gene; Modifier gene; Plasma total cholesterol (TC); Single nucleotide polymorphism (SNP)

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FEMALE; G SUBSTRATE GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; JAPAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; JAPAN; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN KINASES; TRIGLYCERIDES;

EID: 0142024021     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-003-0055-x     Document Type: Article

References (20)

1. Cullen P, Funke H, Schulte H, Assmann G. (1997) Lipoproteins and cardiovascular risk-from genetics to CHD prevention. J Atheroscler Thromb 4:51-58
2. Endo S, Suzuki M, Sumi M, Nairn AC, Morita R, Yamakawa K, Greengard P, Ito M (1999) Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells. Proc Natl Acad Sci USA 96:2467-2472
3. Goldstein JL, Hobbs HH, Brown MS: Familial hypercholesterolaemia. In: Scriver CT, Beaudet AL, Sly WS, Valle D (eds) (1995) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1981-2030
4. Haga H, Yamada R, Ohnishi, Y, Nakamura Y, Tanaka T (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J Hum Genet 47:605-610
5. Hall KU, Collins SP, Gamm DM, Massa E, DePaoli-Roach AA, Uhler MD (1999) Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate. A Purkinje cell substrate of the cyclic GMP-dependent protein kinase. J Biol Chem 274:3485-95
6. Harada H, Nagai H, Tsuneizumi M, Mikami I, Sugano S, Emi M (2001) Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers. J Hum Genet 46:90-95
7. Hattori H, Hirayama T, Nobe Y, Nagano M, Kujiraoka T, Egashira T, Ishii J, Tsuji M, Emi M (2002) Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of Japan. J Hum Genet 47:80-87
8. Hegele RA (2001) Monogenic dislipidemias: window on determinants of plasma lipoprotein metabolism. Am J Hum Genet 69:1161-1177
9. Ishii J, Nagano M, Kujiraoka T, Ishihara M, Egashira T, Takada D, Tsuji M, Hattori H, Emi M (2002) Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis. J Hum Genet 47:366-369
10. Lalouel JM, Rohrwasser A (2001) Development of genetic hypotheses in essential hypertension. J Hum Genet 46:299-306
11. Matsuzawa Y (1995) Significance of hyperglycemia in the occurrence of ischemic heart disease. J Atheroscler Thromb 2:S26-28
12. Nakazawa I, Nakajima T, Harada H, Ishigami T, Umemura S, Emi M (2001) Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysis. J Hum Genet 46:132-136
13. Norioka M, Suzuki M, Ryomoto K, Ikebuchi M, Harano Y (2000) Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects. J Atheroscler Thromb 7:198-202
14. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki, H, Nakamura Y (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46:471-477
15. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M (2001) A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 46:267-272
16. Shastry B S (2002) SNP alleles in human disease and evolution. J Hum Genet 47:561-566
17. Shinohara Y, Ezura Y, Iwasaki H, Nakazawa I, Ishida R, Kodaira M, Kajita M, Shiba T, Emi M (2001) Linkage disequilibrium and haplotype analysis among ten single-nucleotide polymorphisms of interleukin 11 identified by sequencing of the gene. J Hum Genet 46:494-497
18. Szeto HH (2003) Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development. Life Sci 73:749-58
19. Takada D, Emi M, Ezura Y, Nobe Y, Kawamura K, Iino Y, Katayama Y, Xin Y, Wu LL, Shum SL, Stephenson SH, Hunt SC, Hopkins PN (2002) Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: Molecular study in a 1135-member familial hypercholesterolemia kindred. J Hum Genet 47:656-664
20. Zannis VI, Breslow JL (1985) Genetic mutations affecting human lipoprotein metabolism. Adv Hum Genet 14:125-215